Condition (MeSH)
Cryptorchidism
ClinicalTrials.gov lists 37 trials for Cryptorchidism or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase (log scale)
37 of the 37 trials are tagged with Cryptorchidism itself; the rest are tagged with a narrower condition beneath it.
When did Cryptorchidism trials start? (17)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 6
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 4 |
| 2024 | 6 |
| 2022 | 2 |
| 2021 | 2 |
| 2020 | 2 |
| 2019 | 1 |
| 2018 | 2 |
| 2017 | 2 |
| 2015 | 2 |
Showing 10 of 17 earlier years.
No forecast is made for this condition: it averages 2.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Cryptorchidism trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 1 |
| Phase 4 | 1 |
| Not applicable | 20 |
| Observational | 14 |
How many Cryptorchidism trials are recruiting? (6)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 2 |
| Recruiting | 7 |
| Active, not recruiting | 1 |
| Completed | 18 |
| Terminated | 1 |
Showing 5 of 6 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which drugs are being tested for Cryptorchidism? (1)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| PROPOFOL | 2 |
Interventions as named in the registry (14)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| 1% Sevoflurane | 3 |
| Laparoscopy | 2 |
| Ropivacaine 2 % | 1 |
| Exparel 133 miligrams per 10 milliliter injection | 1 |
| Caudal block | 1 |
Showing 5 of 14 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Cryptorchidism? (86)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Does the contralateral testicular volume decide the need for diagnostic laparoscopy in cases of unilateral impalpable undescended testis? | BMC urology | 2024 | Yes |
| Temporal decline of sperm concentration: role of endocrine disruptors. | Endocrine | 2023 | Yes |
| MicroRNA as epigenetic regulators of canine cryptorchidism. | Research in veterinary science | 2023 | Yes |
| Elevated plasma miR-210 expression is associated with atypical genitalia in patients with 46,XY differences in sex development. | Molecular genetics & genomic medicine | 2022 | Yes |
| Clinical effect of minimally invasive surgery for inguinal cryptorchidism. | BMC surgery | 2021 | Yes |
Showing 5 of 86 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.